首页> 美国卫生研究院文献>other >Fiber bundle design for an integrated wearable artificial lung
【2h】

Fiber bundle design for an integrated wearable artificial lung

机译:集成可穿戴人工肺的纤维束设计

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Mechanical ventilation and ECMO are the only viable treatment options for lung failure patients at the end stage, including ARDS and COPD. These treatments however are associated with high morbidity and mortality due to long wait times for lung transplant. Contemporary clinical literature has shown ambulation improves post-transplant outcomes in lung failure patients. Given this, we are developing the PAAL, a truly wearable artificial lung that allows for ambulation. In this study, we targeted 180 ml/min oxygenation and determined the form factor for a hollow fiber membrane (HFM) bundle for the PAAL.Based on a previously published mass transfer correlation we modeled oxygenation efficiency as a function of fiber bundle diameter. Three benchmark fiber bundles were fabricated to validate the model through in-vitro blood gas exchange at blood flow rates from 1 to 4 L/min according to ASTM standards. We used the model to determine a final design, which was characterized in-vitro through a gas exchange as well as a hemolysis study at 3.5 L/min The percent difference between model predictions and experiment for the benchmark bundles ranged from 3% to 17.5% at the flowrates tested. Using the model, we predicted a 1.75 inch diameter bundle with 0.65 m2 surface area would produce 180 ml/min at 3.5 L/min blood flow rate. The oxygenation efficiency was 278 ml/min/m2 and the Normalized Index of Hemolysis (NIH) was less than 0.05g/100L. Future work involves integrating this bundle into the PAAL for which an experimental prototype is under development in our laboratory.
机译:在末期,包括ARDS和COPD,机械通气和ECMO是肺衰竭患者唯一可行的治疗选择。然而,由于肺移植的等待时间长,这些治疗与高发病率和高死亡率相关。当代临床文献表明,在肺功能衰竭患者中,移动有助于改善移植后的预后。鉴于此,我们正在开发PAAL,这是一种真正的可穿戴人造肺,可以进行行走。在这项研究中,我们以180 ml / min的氧合为目标,并确定了PAAL的中空纤维膜(HFM)束的形状因子。基于先前发布的传质相关性,我们将氧合效率建模为纤维束直径的函数。根据ASTM标准,制造了三个基准纤维束,以通过血液流速为1-4 L / min的体外血气交换来验证模型。我们使用该模型确定最终设计,该设计通过气体交换和3.5 L / min的溶血研究进行体外表征。模型预测与基准束实验之间的百分比差异为3%至17.5%以测试的流量。使用该模型,我们预测直径为1.75英寸的束具有0.65 m 2 表面积,以3.5 L / min的血流速度可产生180 ml / min。氧合效率为278 ml / min / m 2 ,溶血归一化指数(NIH)小于0.05g / 100L。未来的工作涉及将该捆绑包集成到PAAL中,我们实验室正在为其开发实验原型。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号